Company intelligence / Profile preview

Chang Gung

Linkou, New Taipei, Taiwancgu.edu.tw ↗

Ownership: Private
Development stage: Other

Overview

Chang Gung Memorial Hospital is Taiwan’s largest healthcare provider with over 10 branches nationwide offering comprehensive acute and chronic care services. It operates Asia’s largest proton therapy center and has received international accreditation for quality of care. Its Chiayi branch recently won an ESG award for dramatically improving outcomes in necrotizing fasciitis through multidisciplinary innovation[3][5]. The associated biotechnology arm holds patents on probiotic therapies targeting metabolic diseases such as fatty liver disease and type 2 diabetes[6].

Therapeutic areas: OtherEndocrinologyMetabolic DisordersGastroenterology
Modalities: Probiotic therapyPolysaccharide-based therapy
Industry: Academic Hospital/University/Research

Beyond the preview

Go deeper on Chang Gung.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chang Gung.

Explore the full profile